{"pageContent": "The CEASAR study uses patient-reported outcomes to provide actionable quality-of-life data for shared-decision making for patients with localized prostate cancer.", "metaData": {"source": "Outcomes of T3a Prostate Cancer with Unfavorable Prognostic Factors Treated with Brachytherapy Combined with External Radiotherapy and Hormone Therapy\nhttps://pubmed.ncbi.nlm.nih.gov/26564412/"}}